AveXis, Inc. IPO Research Information

AveXis, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on AveXis, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
AveXis, Inc.	AVXS - NASDAQ	$19.00-$21.00	$20.00	$18.02	4.75 million	2/11/2016
Underwriter(s): Goldman Sachs & Co., Jefferies
Co-Manager(s): BMO Capital Markets, Chardan
Industry: Health Care
Filing(s): Filed 2016-01-15 Terms Added 2016-02-01

AveXis, Inc. Quote & Chart - Click for current quote - AVXS

About AveXis, Inc. (adapted from AveXis, Inc. prospectus):
They are a clinical-stage gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AVXS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.